Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shafak Aluwini

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|July 3, 2025
RADIOSA and the management of oligorecurrent prostate cancer: a step forward, but the journey continuesShafak Aluwini, Ruth van der Walle, Jorinde Janssen
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Noncoplanar Beam Angle Class Solutions to Replace Time-Consuming Patient-Specific Beam Angle Optimization in Robotic Prostate Stereotactic Body Radiation TherapyLinda Rossi, Sebastiaan Breedveld, Shafak Aluwini, et al.
The Lancet. Oncology|July 31, 2025
Reflections on the PEACE V-STORM trialShafak Aluwini, Ruth van der Walle, Walter Noordzij
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2011
HDR monotherapy for prostate cancer: a simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiationInger-Karine K Kolkman-Deurloo, Martin A Roos, Shafak Aluwini
Radiation Oncology (London, England)|April 11, 2013
Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early resultsShafak Aluwini, Peter van Rooij, Mischa Hoogeman, et al.
European Urology Open Science|November 21, 2025
Reply to Birhan Demirhan, Aysenur Elmali, and Cem Onal's Letter to the Editor re: Daniela E. Oprea-Lagera, Tessa van Elst, Shafak Aluwini, et al. How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View. Eur Urol Open Sci 2025;75:69-79Daniela Oprea-Lager, Tessa van Elst, Shafak Aluwini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 5, 2018
Texture analysis of 3D dose distributions for predictive modelling of toxicity rates in radiotherapyLinda Rossi, Rik Bijman, Wilco Schillemans, et al.
Clinical and Translational Radiation Oncology|July 18, 2018
Salvage radiotherapy after radical prostatectomy: Long-term results of urinary incontinence, toxicity and treatment outcomesLisanne F van Dessel, Sarah H M Reuvers, Chris H Bangma, et al.
Acta Oncologica (Stockholm, Sweden)|July 4, 2018
First fully automated planning solution for robotic radiosurgery - comparison with automatically planned volumetric arc therapy for prostate cancerLinda Rossi, Abdul Wahab Sharfo, Shafak Aluwini, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Intrafraction prostate translations and rotations during hypofractionated robotic radiation surgery: dosimetric impact of correction strategies and marginsSteven van de Water, Lorella Valli, Shafak Aluwini, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|July 3, 2025
RADIOSA and the management of oligorecurrent prostate cancer: a step forward, but the journey continuesShafak Aluwini, Ruth van der Walle, Jorinde Janssen
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Noncoplanar Beam Angle Class Solutions to Replace Time-Consuming Patient-Specific Beam Angle Optimization in Robotic Prostate Stereotactic Body Radiation TherapyLinda Rossi, Sebastiaan Breedveld, Shafak Aluwini, et al.
The Lancet. Oncology|July 31, 2025
Reflections on the PEACE V-STORM trialShafak Aluwini, Ruth van der Walle, Walter Noordzij
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2011
HDR monotherapy for prostate cancer: a simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiationInger-Karine K Kolkman-Deurloo, Martin A Roos, Shafak Aluwini
Radiation Oncology (London, England)|April 11, 2013
Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early resultsShafak Aluwini, Peter van Rooij, Mischa Hoogeman, et al.
European Urology Open Science|November 21, 2025
Reply to Birhan Demirhan, Aysenur Elmali, and Cem Onal's Letter to the Editor re: Daniela E. Oprea-Lagera, Tessa van Elst, Shafak Aluwini, et al. How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View. Eur Urol Open Sci 2025;75:69-79Daniela Oprea-Lager, Tessa van Elst, Shafak Aluwini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 5, 2018
Texture analysis of 3D dose distributions for predictive modelling of toxicity rates in radiotherapyLinda Rossi, Rik Bijman, Wilco Schillemans, et al.
Clinical and Translational Radiation Oncology|July 18, 2018
Salvage radiotherapy after radical prostatectomy: Long-term results of urinary incontinence, toxicity and treatment outcomesLisanne F van Dessel, Sarah H M Reuvers, Chris H Bangma, et al.
Acta Oncologica (Stockholm, Sweden)|July 4, 2018
First fully automated planning solution for robotic radiosurgery - comparison with automatically planned volumetric arc therapy for prostate cancerLinda Rossi, Abdul Wahab Sharfo, Shafak Aluwini, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Intrafraction prostate translations and rotations during hypofractionated robotic radiation surgery: dosimetric impact of correction strategies and marginsSteven van de Water, Lorella Valli, Shafak Aluwini, et al.
Pageof 5